Rectal Cancer: Locally Advanced and Recurrent

  • Robert R. Cima


Of patients with newly diagnosed colorectal cancer who will undergo surgery with curative intent as part of their treatment, approximately 5–12% will have tumors that have spread beyond the anatomic landmarks of a standard resection and have invaded adjacent organs or structures.1–3 The goal of surgery in such cases is a wide, en bloc resection of the tumor and any involved adjacent organ or structure. Of patients who undergo resection with curative intent and receive adjuvant therapy, between 7 and 33% develop isolated local or regional recurrences.4,5 In up to 20% of these recurrences, resection can be curative.4,6,7


  1. 1.
    Curly SA, Carlson GW, Shumate CR, et al. Extended resection for locally advanced colorectal carcinoma. Am J Surg. 1992;163:553–9.CrossRefGoogle Scholar
  2. 2.
    Polk Jr HC. Extended resection for selected adenocarcinomas of the large bowel. Ann Surg. 1972;175:892–9.CrossRefGoogle Scholar
  3. 3.
    Bonfanti G, Bozzetti F, Doci R, et al. Results of extended surgery for cancer of the rectum and sigmoid. Br J Surg. 1982;69:305–7.CrossRefGoogle Scholar
  4. 4.
    McDermott FT, Hughes ES, Pihl E, et al. Local recurrence after potentially curative resection for rectal cancer in a series of 1008 patients. Br J Surg. 1985;72:34–7.CrossRefGoogle Scholar
  5. 5.
    Wanebo HJ, Koness RJ, Vezeridas MP. Pelvic resection of recurrent rectal cancer. Ann Surg. 1994;220:586–97.CrossRefGoogle Scholar
  6. 6.
    Philipshen SJ, Heilweil M, Quan SHQ, et al. Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer. 1984;53:1354–62.CrossRefGoogle Scholar
  7. 7.
    Rich T, Gunderson LL, Lew R, et al. Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer. 1983;52:1317–29.CrossRefGoogle Scholar
  8. 8.
    Gunderson LJ, Sargent DJ, Tepper JE, et al. Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis. Int J Radiat Oncol Biol Phys. 2002;54:386–96.CrossRefGoogle Scholar
  9. 9.
    Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1:1479–82.CrossRefGoogle Scholar
  10. 10.
    MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet. 1993;341:457–60.CrossRefGoogle Scholar
  11. 11.
    Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in respectable rectal cancer. N Engl J Med. 1997;336:980–7.CrossRefGoogle Scholar
  12. 12.
    Camma C, Giunta M, Fiorica F, et al. Preoperative radiotherapy for respectable rectal cancer: a meta-analysis. J Am Med Assoc. 2000;284:1008–15.CrossRefGoogle Scholar
  13. 13.
    Kramer T, Share R, Kiel K, et al. Intraoperative radiation therapy of colorectal cancer. In: Abe M, editor. Intraoperative radiation therapy. New York: Pergamon; 1991. p. 308–10.Google Scholar
  14. 14.
    Wong CS, Cummings BJ, Brierley JD, et al. Treatment of locally recurrent rectal carcinoma-results and prognostic factors. Int J Radiat Oncol Biol Phys. 1998;40:427–35.CrossRefGoogle Scholar
  15. 15.
    Knol HP, Hanssens PE, Rutten HJ, et al. Effects of radiation therapy alone or in combination with surgery and/or chemotherapy on tumor and symptom control of recurrent rectal cancer. Strahlenther Onkol. 1997;173:43–9.CrossRefGoogle Scholar
  16. 16.
    Hruby G, Barton M, Miles S, et al. Site of local recurrence after surgery, with or without chemotherapy, for rectal cancer: implications for radiotherapy field design. Int J Radiat Oncol Biol Phys. 2003;55:138–43.CrossRefGoogle Scholar
  17. 17.
    Farouk R, Nelson H, Radice E, et al. Accuracy of computed tomography in determining resectability for locally advanced primary or recurrent colorectal cancers. Am J Surg. 1998;175:283–7.CrossRefGoogle Scholar
  18. 18.
    Moore HG, Akhurst T, Larson SM, et al. A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients. J Am Coll Surg. 2003;197:22–8.CrossRefGoogle Scholar
  19. 19.
    Ogunbiyi OA, Flanagan FL, Dehdashti F, et al. Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol. 1997;4:613–20.CrossRefGoogle Scholar
  20. 20.
    Miller E, Lerman H, Gutman M, et al. The clinical impact of camera-based positron emission tomography imaging in patients with recurrent colorectal cancer. Invest Radiol. 2004;39:8–12.CrossRefGoogle Scholar
  21. 21.
    Valk PE, Abella-Columna E, Haseman MK, et al. Whole-body PET imaging with [18F] fluorodeoxyglucose in management of recurrent colorectal cancer. Arch Surg. 1999;134:503–11.CrossRefGoogle Scholar
  22. 22.
    Arulampalam T, Costa D, Visvikis D, et al. The impact of FDG-PET on the management algorithm for recurrent colorectal cancer. Eur J Nucl Med. 2001;28:1758–65.CrossRefGoogle Scholar
  23. 23.
    Whiteford MH, Whiteford HM, Yee LF, et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum. 2000;53:759–70.CrossRefGoogle Scholar
  24. 24.
    Suzuki K, Dozois RR, Devine RM, et al. Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum. 1996;39:730–6.CrossRefGoogle Scholar
  25. 25.
    Guiney MJ, Smith JG, Worotniuk V, et al. Radiotherapy treatment for isolated loco-regional recurrence of rectosigmoid cancer following definitive surgery: Peter Maccallum Cancer Institute experience, 1981-1990. Int J Radiat Oncol Biol Phys. 1997;38:1019–25.CrossRefGoogle Scholar
  26. 26.
    Aleksic M, Hennes N, Ulrich B. Surgical treatment of locally advanced rectal cancer. Options and strategies. Dig Surg. 1998;15:342–6.CrossRefGoogle Scholar
  27. 27.
    Rau B, Hohenberger P, Gellermann J, et al. T4 rectal carcinoma. Surgical and multimodal therapy. Chirug. 2002;73:147–1453.CrossRefGoogle Scholar
  28. 28.
    Platell C, Cassidy B, Heywood J, et al. Use of adjuvant, preoperative chemo-radiotherapy in patients with locally advanced rectal cancer. ANZ J Surg. 2002;72:639–42.CrossRefGoogle Scholar
  29. 29.
    Gohl J, Merkel S, Rodel C, et al. Can neoadjuvant radiochemotherapy improve the results of multivisceral resections in the advanced rectal carcinoma (cT4a). Colorectal Dis. 2003;5:436–41.CrossRefGoogle Scholar
  30. 30.
    Pacelli F, Tortorelli AP, Rosa F, et al. Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy. Ann Surg Oncol. 2010;17(1):152–62.CrossRefGoogle Scholar
  31. 31.
    Hansen MH, Balteskard L, Dǿrum LM, Eriksen MT, et al. Locally recurrent rectal cancer in Norway. Br J Surg. 2009;96:1176–82.CrossRefGoogle Scholar
  32. 32.
    Heriot AG, Byrne CM, Lee P, et al. Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum. 2008;51:284–91.CrossRefGoogle Scholar
  33. 33.
    Ferenschild FTJ, Vermaas M, Verhoef C, et al. Abdominosacral resection for locally advanced and recurrent rectal cancer. Br J Surg. 2009;96:1341–7.CrossRefGoogle Scholar
  34. 34.
    Alektiar KM, Zelefsky MJ, Paty PB, et al. High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer. Int J Radiat Oncol Biol Phys. 2000;48:219–26.CrossRefGoogle Scholar
  35. 35.
    Keuhne J, Kleisli T, Biernacki P, et al. Use of high-dose-rate brachytherapy in the management of locally recurrent rectal cancer. Dis Colon Rectum. 2003;46:895–9.CrossRefGoogle Scholar
  36. 36.
    Martinez-Monge R, Nag S, Martin EW. 125Iodine brachytherapy for colorectal adenocarcinoma recurrent in the pelvis and paraortics. Int J Radiat Oncol Biol Phys. 1998;42:545–50.CrossRefGoogle Scholar
  37. 37.
    Goes RN, Beart RW, Simons AJ, et al. Use of brachytherapy in management of locally recurrent rectal cancer. Dis Colon Rectum. 1997;40:1177–9.CrossRefGoogle Scholar
  38. 38.
    Martinez-Monge R, Nag S, Martin EW. Three different intraoperative radiation modalities (electron beam, high-dose-rate brachytherapy, and iodine-125 brachytherapy) in the adjuvant treatment of patient with recurrent colorectal adenocarcinoma. Cancer. 1999;86:236–47.CrossRefGoogle Scholar
  39. 39.
    Weinstein GD, Rich TA, Shumate CR, et al. Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer. Int J Radiat Oncol Biol Phys. 1995;32:197–204.CrossRefGoogle Scholar
  40. 40.
    Harrison LB, Minsky BD, Enker WE, et al. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced and recurrent rectal cancer. Int J Radiat Oncol Biol Phys. 1998;42:325–30.CrossRefGoogle Scholar
  41. 41.
    Willett CG, Shellito PC, Tepper JE, et al. Intraoperative electron beam radiation therapy for recurrent locally advanced rectal or rectosigmoid carcinoma. Cancer. 1991;67:1504–8.CrossRefGoogle Scholar
  42. 42.
    Valentini V, Morganti AG, Gambacorta MA, et al. Preoperative hyper-fractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: a multicentric phase II study. Int J Radiat Oncol Biol Phys. 2006;64:1129–39.CrossRefGoogle Scholar
  43. 43.
    Neagle CE, Schaffer JL, Heppenstall RB. Compartment syndrome complicating prolonged use of the lithotomy position. Surgery. 1991;110:566–9.PubMedGoogle Scholar
  44. 44.
    Kim HK, Jessup JM, Beard CJ, et al. Locally advanced rectal carcinoma: pelvic control and morbidity following preoperative radiation therapy, resection and intraoperative radiation therapy. Int J Radiat Oncol Biol Phys. 1997;38:777–83.CrossRefGoogle Scholar
  45. 45.
    Kapiteijin E, Marijnen CAM, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638–46.CrossRefGoogle Scholar
  46. 46.
    Tepper JE, O’Connell M, Niedzwiecki D, et al. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control – final report of intergroup 0114. J Clin Oncol. 2002;20:1744–50.CrossRefGoogle Scholar
  47. 47.
    Lindel K, Willett CG, Shellito PC, et al. Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer. Radiother Oncol. 2001;58:83–7.CrossRefGoogle Scholar
  48. 48.
    Hashiguchi Y, Sekine T, Sakamoto H, et al. Intraoperative irradiation after surgery for locally recurrent rectal cancer. Dis Colon Rectum. 1999;42:886–93.CrossRefGoogle Scholar
  49. 49.
    Lingareddy V, Ahmad NR, Mohiuddin M. Palliative reirradiation for recurrent rectal cancer. Int J Radiat Oncol Biol Phys. 1997;38:785–90.CrossRefGoogle Scholar
  50. 50.
    Garcia-Aguilar J, Cromwell JW, Marra C, et al. Treatment of locally recurrent rectal cancer. Dis Colon Rectum. 2001;44:1743–8.CrossRefGoogle Scholar
  51. 51.
    Hahnloser D, Nelson H, Gunderson LL, et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg. 2003;237:502–8.PubMedPubMedCentralGoogle Scholar
  52. 52.
    Mannaerts G, Rutten HJT, Martijin H, et al. Comparison of intraoperative radiation therapy-containing multimodality treatment with historical treatment modalities for locally recurrent rectal cancer. Dis Colon Rectum. 2001;44:1749–58.CrossRefGoogle Scholar
  53. 53.
    Mannaerts G, Martijin H, Crommelin MA, et al. Feasibility and first results of multimodality treatment, combining EBRT, extensive surgery, and IOERT in locally advanced primary rectal cancer. Int J Radiat Oncol Biol Phys. 2000;47:425–33.CrossRefGoogle Scholar
  54. 54.
    Haddock MG, Gunderson LL, Nelson H, et al. Intraoperative irradiation for locally recurrent colorectal cancer in previously irradiated patients. Int J Radiat Oncol Biol Phys. 2001;49:1267–74.CrossRefGoogle Scholar
  55. 55.
    Calvo FA, Gomez-Espi M, Diaz-Gonzalez JA, et al. Intraoperative presacral electron boost following preoperative chemoradiation in T3-4Nx rectal cancer: initial local effects and clinical outcomes analysis. Radiother Oncol. 2002;62:201–6.CrossRefGoogle Scholar
  56. 56.
    Bussieres E, Gilly FN, Rouanet P, et al. Recurrences of rectal cancers: results of a multimodal approach with intraoperative radiation therapy. Int J Radiat Oncol Biol Phys. 1996;34:49–56.CrossRefGoogle Scholar
  57. 57.
    Shoup M, Guillem JG, Alektiar KM, et al. Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy. Dis Colon Rectum. 2002;45:585–92.CrossRefGoogle Scholar
  58. 58.
    Nuyttens JJ, Kolkman-Deurloo IK, Vermaas M, et al. High dose-rate intraoperative radiotherapy for close or positive margins in patients with locally advanced or recurrent rectal cancer. Int J Radiat Oncol Biol Phys. 2004;58:106–12.CrossRefGoogle Scholar
  59. 59.
    Wiig JN, Poulsen JP, Tveit KM, Olsen DR, Giercksky KE. Intraoperative irradiation (IORT) for primary advanced and recurrent rectal cancer: a need for randomised studies. Eur J Cancer. 2000;36:868–74.CrossRefGoogle Scholar
  60. 60.
    Wiig JN, Tveit KM, Poulsen JP, Olsen DR, Giercksky KE. Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study. Radiother Oncol. 2002;62:207–13.CrossRefGoogle Scholar
  61. 61.
    Allum WH, Mack P, Priestman TJ, et al. Radiotherapy for pain relief in locally recurrent colorectal cancer. Ann R Coll Surg Engl. 1987;69:220–1.PubMedPubMedCentralGoogle Scholar
  62. 62.
    Whiteley Jr HW, Stearns Jr MW, Leaming RH, et al. Palliative radiation therapy in patients with cancer of the colon and rectum. Cancer. 1970;25:343–6.CrossRefGoogle Scholar
  63. 63.
    Baron TH. Indications and results of endoscopic rectal stenting. J Gastrointest Surg. 2004;8:266–9.CrossRefGoogle Scholar
  64. 64.
    Khot UP, Lang AW, Murali K, et al. Systematic review of the efficacy and safety of colorectal stents. Br J Surg. 2002;89:1096–102.CrossRefGoogle Scholar
  65. 65.
    Spinelli P, Mancini A. Use of self-expanding emtal stents for palliation of rectosigmoid cancer. Gastrointest Endosc. 2001;53:203–6.CrossRefGoogle Scholar
  66. 66.
    Kimmey MB. Endoscopic methods (other than stents) for palliation of rectal carcinoma. J Gastrointest Surg. 2004;8:270–3.CrossRefGoogle Scholar
  67. 67.
    McGowan I, Barr H, Krasner N. Palliative laser therapy for inoperable rectal cancer-does it work. Cancer. 1989;63:967–9.CrossRefGoogle Scholar
  68. 68.
    Cutsem EV, Boonen A, Geboes K, et al. Risk factors which determine the long-term outcome of Neodymium-YAG laser palliation of colorectal carcinoma. Int J Colorectal Dis. 1989;4:9–11.CrossRefGoogle Scholar
  69. 69.
    Nash GM, Saltz LB, Kemeny NE, et al. Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease. Ann Surg Oncol. 2002;9:954–60.CrossRefGoogle Scholar

Copyright information

© ASCRS (American Society of Colon and Rectal Surgeons) 2011

Authors and Affiliations

  • Robert R. Cima
    • 1
  1. 1.Associate Professor of SurgeryMayo ClinicRochesterUSA

Personalised recommendations